Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Dylewski

Thoracic Surgery (Cardiothoracic Vascular Surgery) Miami, FL Medical Doctor

NPI 1235136151 CMS profile 100732

8900 N. Kendall Dr, Miami Cancer Institute, Miami, FL 33176

Open in the dashboard

General payments

$278,662

471 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$500 paid to institutions, not to them · program year 2019

Through program year 2025, Mark Dylewski of Miami, FL is reported in the CMS Open Payments database as having received $278,662 across 471 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,835 69
2024 General $59,839 94
2023 General $64,290 69
2022 General $13,645 33
2021 General $27,352 34
2020 General $45,936 70
2019 General $46,765 102

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Dylewski
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Mark Dylewski were reported at $20,835. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Mark Dylewski Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $46,765 $886 $178–$3,167 $163
2020 $45,936 $341 $108–$1,605 $114
2021 $27,352 $453 $125–$1,886 $132
2022 $13,645 $695 $180–$2,566 $149
2023 $64,290 $745 $205–$2,662 $160
2024 $59,839 $799 $214–$2,967 $164
2025 $20,835 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $173,833 220 payments
  2. Ethicon Inc. $70,882 75 payments
  3. Medical Device Business Services, Inc. $11,382 18 payments
  4. Noah Medical Corporation $7,692 8 payments
  5. Atricure, Inc. $3,952 53 payments
  6. Ethicon Endo-Surgery Inc. $3,454 5 payments
  7. Davol Inc. $2,603 49 payments
  8. Ethicon US, LLC $2,360 12 payments
  9. Medtronic, Inc. $811 1 payment
  10. Zimmer Biomet Holdings, Inc. $603 13 payments
  11. Other $1,091 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $134,160 40 payments
  2. Consulting Fee $70,169 40 payments
  3. Travel and Lodging $31,907 81 payments
  4. Food and Beverage $24,276 298 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,150 12 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $173,683 219 payments
  2. Monarch $12,600 8 payments
  3. Monarch Platform $7,046 24 payments
  4. Echelon; Endopath $4,354 8 payments
  5. ECHELON ENDOPATH $4,212 6 payments
  6. MATRIXMIDFACE $3,915 1 payment
  7. ECHELON FLEX Stapler $3,210 3 payments
  8. Echelon Flex $3,101 12 payments
  9. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $1,908 26 payments
  10. AtriCure cryoICE cryoSPHERE Cryoablation System $1,904 27 payments
  11. Other $5,813 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

104

Median for Thoracic Surgery: 42

Drug cost

$1,336

Median for Thoracic Surgery: $318

Branded share of claims

100%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 64 $1,102
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 40 $235

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 74 billing codes

Paid by Medicare

$156,599

Medicare's payments for the services billed

Medicare patients

166

Average age 74

Services billed

417

87 women, 79 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 69%
Ischemic heart disease 52%
COPD 51%
Arthritis 50%
Diabetes 28%
Atrial fibrillation 26%
Depression 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RYBREVANT
  • Janssen Biotech, Inc. $23
$23 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

471 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record